The Correlation Study of Hypnotic Drugs on the Cognitive Function of Patients With Chronic Insomnia.
NCT04996953 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 165
Last updated 2021-08-16
Summary
All the subjects were assessed for sleep quality, anxiety and depression, and cognitive function. Based on their previous hypnotic medication history, they were divided into a non-medicine group and a benzodiazepine group,and the group taking non-benzodiazepine drugs.The cognitive effects of different hypnotic drugs on patients were evaluated by comparing sleep related scale and cognitive function scale.
Conditions
- Insomnia Chronic
Sponsors & Collaborators
-
Lili Cao
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-06-01
- Primary Completion
- 2024-07-01
- Completion
- 2025-07-01
Countries
- China
Study Locations
More Related Trials
-
Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients
NCT05618002 ·Status: RECRUITING
-
Chinese Medicine in Treating Insomnia
NCT06511011 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Ramelteon in Chinese Patients With Chronic Insomnia
NCT06512363 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Cognitive-Behavioural and Hypnotic Treatment of Chronic Primary Insomnia Among the Elderly
NCT00295386 ·Status: COMPLETED ·Phase: PHASE4
-
Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder
NCT06279286 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study on the Efficacy and Safety of Anesthesia-Induced Sleep Therapy for Refractory Insomnia
NCT07255027 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy of Chronic Hypnotic Use
NCT01006525 ·Status: COMPLETED
-
ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults
NCT06333145 ·Status: RECRUITING ·Phase: PHASE4
-
Stilnox Treatment in Elderly Patients With Insomnia
NCT00359229 ·Status: COMPLETED ·Phase: PHASE4
-
Sleep Satisfaction and Psychomotor Performance of Adults
NCT01097382 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
NCT01243060 ·Status: COMPLETED ·Phase: NA
-
Changes in Rimazolen Dosage in Insomnia Patients Undergoing Digestive Endoscopy
NCT07028190 ·Status: RECRUITING
-
The Potential Benefit of Xiao-Yao-San Treatment in Patients With Insomnia
NCT06417515 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Discontinuation of Benzodiazepine-derivative Hypnotics on Cognitive and Motor Functions in Elderly Persons
NCT00707915 ·Status: COMPLETED ·Phase: PHASE4
-
Investigating Racing Thoughts in Patients With Insomnia Disorder
NCT04752254 ·Status: UNKNOWN
-
The Effect of Valerian on Insomnia in Menopausal Women
NCT05185219 ·Status: RECRUITING ·Phase: NA
-
Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug
NCT04299490 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Behavioral/Pharmacological Therapy for Insomnia
NCT00044629 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia
NCT00426816 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers
NCT00722306 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Chronic Hypnotic Use 2
NCT02456532 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care.
NCT06638710 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants
NCT06673927 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia
NCT01995838 ·Status: COMPLETED ·Phase: PHASE2
-
Behavioral and Pharmacological Treatment for Insomnia
NCT00042146 ·Status: COMPLETED ·Phase: PHASE4